Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ecogen sales and marketing update

EECN's product sales were $2.8 million in the second quarter ended June

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE